These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 9620988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor.
    Lin X, Lubinski JM, Friedman HM.
    J Virol; 2004 Mar; 78(5):2562-71. PubMed ID: 14963159
    [Abstract] [Full Text] [Related]

  • 4. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells.
    Dingwell KS, Brunetti CR, Hendricks RL, Tang Q, Tang M, Rainbow AJ, Johnson DC.
    J Virol; 1994 Feb; 68(2):834-45. PubMed ID: 8289387
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
    Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM.
    J Virol; 2008 Jul; 82(14):6935-41. PubMed ID: 18480440
    [Abstract] [Full Text] [Related]

  • 8. Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease.
    Saldanha CE, Lubinski J, Martin C, Nagashunmugam T, Wang L, van Der Keyl H, Tal-Singer R, Friedman HM.
    J Virol; 2000 Aug; 74(15):6712-9. PubMed ID: 10888608
    [Abstract] [Full Text] [Related]

  • 9. Immune evasion by herpes simplex virus type 1, strategies for virus survival.
    Friedman HM.
    Trans Am Clin Climatol Assoc; 2003 Aug; 114():103-12. PubMed ID: 12813914
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.
    Awasthi S, Lubinski JM, Friedman HM.
    Vaccine; 2009 Nov 16; 27(49):6845-53. PubMed ID: 19761834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus.
    Dingwell KS, Doering LC, Johnson DC.
    J Virol; 1995 Nov 16; 69(11):7087-98. PubMed ID: 7474128
    [Abstract] [Full Text] [Related]

  • 17. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
    Komala Sari T, Gianopulos KA, Nicola AV.
    J Virol; 2020 Feb 14; 94(5):. PubMed ID: 31826995
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Responses of herpes simplex virus type 1-infected cells to the presence of extracellular antibodies: gE-dependent glycoprotein capping and enhancement in cell-to-cell spread.
    Rizvi SM, Raghavan M.
    J Virol; 2003 Jan 14; 77(1):701-8. PubMed ID: 12477873
    [Abstract] [Full Text] [Related]

  • 20. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I.
    Ng TI, Ogle WO, Roizman B.
    Virology; 1998 Feb 01; 241(1):37-48. PubMed ID: 9454715
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.